Rob Dillard

DocwireNews

An augmentation of lymphocyte/monocyte ratio (LMR) value in chronic lymphocytic leukemia (CLL) is correlated with a decline in survival, according to a study published in the Journal of Hematology.&nbsp;Researchers sought to determine the relationship of LMR value in CLL, which they noted has previously shown to be a prognostic factor in various solid organ tumors and certain hematological cancers. In this retrospective study, they assessed 173 patients who were followed between 2005 and 2019. The researchers then evaluated diagnostic age, gender, laboratory, absolute lymphocyte, monocyte count, LMR and overall survival (OS), treatment and responses, recurrence, cytogenetic subtype, and mortality rates for analysis.According to the results of the study, the median LMR was 26.7, and it was considered as cutoff value of 26, the researchers noted. They observed a positive association between LMR and Rai Stage. &ldquo;LMR was significantly higher in patients who have an indication for treatment or who died,&rdquo; the researchers wrote of the results.They concluded, &ldquo;In our study, in CLL, LMR has been shown to be over 26 in advanced stages, in relapse, or with indication of a treatment. With the increase of LMR, it was found that survival and disease-free gap decreased.&rdquo;

BMI Modifies the Relationship Between Glycemic Status and Asthma Severity in Children

Asthma

Jordana Jampel

Cutaneous Melanoma: Sun Protection Behaviors and UV Exposure in Canada

Melanoma

Leah Lawrence

Significant Cardiac Benefit Seen With Ifetroban in Patients With Duchenne Muscular Dystrophy

Neurology

Latest News

Lymphocyte/Monocyte Ratio Associated with Survival Duration in CLL

Oncology

An augmentation of lymphocyte/monocyte ratio (LMR) value in chronic lymphocytic leukemia (CLL) is correlated with a decline in survival, according to a study published in the ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe